AL
KLAC icon

Aspiriant LLC’s KLA KLAC Stock Holding History

Aspiriant LLC’s Portfolio KLAC Stock Details KLAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$359K Buy
+1,190
New +$236K 0.01% 294

Other funds holding KLAC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Aspiriant LLC's KLAC Position: Q2 2026 in Review

Aspiriant LLC opened a new position in KLA (KLAC) in Q2 2026: 1,190 shares worth $359K. The stake represents 0.01% of the portfolio and ranks #294 among its holdings.

2,474 funds tracked by Wall St. Rank hold KLAC as of Q2 2026.

  • Aspiriant LLC held 1,190 shares of KLA worth $359K as of Q2 2026.
  • KLA was a new Aspiriant LLC position in Q2 2026.
  • KLA made up 0.01% of Aspiriant LLC's portfolio in Q2 2026, its #294 holding.
  • 2,474 funds tracked by Wall St. Rank held KLA as of Q2 2026.

Based on Aspiriant LLC's 13F filing for Q2 2026, filed 20 Jul 2026.